ArticleBMJ open2023

Optimum duration of extended adjuvant endocrine therapy in patients with hormone receptor-positive breast cancer: protocol for a network meta-analysis of randomised controlled trials.

Qiancheng Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.